Datasets:

acmc
/

beamit-annotated_full_texts_dataset

Tags:

Dataset card Viewer Files Files and versions Community

Dataset Viewer

Auto-converted to Parquet

View in Dataset Viewer

Split (3)

train · 3.5k rows

title stringlengths 4 295 ⌀	pmid stringlengths 8 8	background_abstract stringlengths 12 1.65k	background_abstract_label stringclasses 12 values	methods_abstract stringlengths 39 1.48k	methods_abstract_label stringlengths 6 31	results_abstract stringlengths 65 1.93k	results_abstract_label stringclasses 10 values	conclusions_abstract stringlengths 57 1.02k	conclusions_abstract_label stringclasses 22 values	mesh_descriptor_names sequence	pmcid stringlengths 6 8	background_title stringlengths 10 86 ⌀	background_text stringlengths 215 23.3k ⌀	methods_title stringlengths 6 74 ⌀	methods_text stringlengths 99 42.9k ⌀	results_title stringlengths 6 172 ⌀	results_text stringlengths 141 62.9k ⌀	conclusions_title stringlengths 9 44 ⌀	conclusions_text stringlengths 5 13.6k ⌀	other_sections_titles sequence	other_sections_texts sequence	other_sections_sec_types sequence	all_sections_titles sequence	all_sections_texts sequence	all_sections_sec_types sequence	keywords sequence	whole_article_text stringlengths 6.93k 126k	whole_article_abstract stringlengths 936 2.95k	background_conclusion_text stringlengths 587 24.7k ⌀	background_conclusion_abstract stringlengths 936 2.83k ⌀	whole_article_text_length int64 1.3k 22.5k	whole_article_abstract_length int64 183 490	other_sections_lengths sequence	num_sections int64 3 28	most_frequent_words sequence	keybert_topics sequence	annotated_base_background_abstract_prompt stringclasses 1 value	annotated_base_methods_abstract_prompt stringclasses 1 value	annotated_base_results_abstract_prompt stringclasses 1 value	annotated_base_conclusions_abstract_prompt stringclasses 1 value	annotated_base_whole_article_abstract_prompt stringclasses 1 value	annotated_base_background_conclusion_abstract_prompt stringclasses 1 value	annotated_keywords_background_abstract_prompt stringlengths 28 460 ⌀	annotated_keywords_methods_abstract_prompt stringlengths 28 701 ⌀	annotated_keywords_results_abstract_prompt stringlengths 28 701 ⌀	annotated_keywords_conclusions_abstract_prompt stringlengths 28 428 ⌀	annotated_keywords_whole_article_abstract_prompt stringlengths 28 701	annotated_keywords_background_conclusion_abstract_prompt stringlengths 28 428 ⌀	annotated_mesh_background_abstract_prompt stringlengths 53 701 ⌀	annotated_mesh_methods_abstract_prompt stringlengths 53 701 ⌀	annotated_mesh_results_abstract_prompt stringlengths 53 692 ⌀	annotated_mesh_conclusions_abstract_prompt stringlengths 54 701 ⌀	annotated_mesh_whole_article_abstract_prompt stringlengths 53 701	annotated_mesh_background_conclusion_abstract_prompt stringlengths 54 701 ⌀	annotated_keybert_background_abstract_prompt stringlengths 100 219 ⌀	annotated_keybert_methods_abstract_prompt stringlengths 100 219 ⌀	annotated_keybert_results_abstract_prompt stringlengths 101 219 ⌀	annotated_keybert_conclusions_abstract_prompt stringlengths 100 240 ⌀	annotated_keybert_whole_article_abstract_prompt stringlengths 100 240	annotated_keybert_background_conclusion_abstract_prompt stringlengths 100 211 ⌀	annotated_most_frequent_background_abstract_prompt stringlengths 67 217 ⌀	annotated_most_frequent_methods_abstract_prompt stringlengths 67 217 ⌀	annotated_most_frequent_results_abstract_prompt stringlengths 67 217 ⌀	annotated_most_frequent_conclusions_abstract_prompt stringlengths 71 217 ⌀	annotated_most_frequent_whole_article_abstract_prompt stringlengths 67 217	annotated_most_frequent_background_conclusion_abstract_prompt stringlengths 71 217 ⌀	annotated_tf_idf_background_abstract_prompt stringlengths 74 283 ⌀	annotated_tf_idf_methods_abstract_prompt stringlengths 67 325 ⌀	annotated_tf_idf_results_abstract_prompt stringlengths 69 340 ⌀	annotated_tf_idf_conclusions_abstract_prompt stringlengths 83 403 ⌀	annotated_tf_idf_whole_article_abstract_prompt stringlengths 70 254	annotated_tf_idf_background_conclusion_abstract_prompt stringlengths 71 254 ⌀	annotated_entity_plan_background_abstract_prompt stringlengths 20 313 ⌀	annotated_entity_plan_methods_abstract_prompt stringlengths 20 452 ⌀	annotated_entity_plan_results_abstract_prompt stringlengths 20 596 ⌀	annotated_entity_plan_conclusions_abstract_prompt stringlengths 20 150 ⌀	annotated_entity_plan_whole_article_abstract_prompt stringlengths 50 758	annotated_entity_plan_background_conclusion_abstract_prompt stringlengths 50 758 ⌀
"Effects of oral alkali drug therapy on clinical outcomes in pre-dialysis chronic kidney disease pat(...TRUNCATED)	35176947	"Metabolic acidosis accelerates the progression of chronic kidney disease (CKD) and increases the mo(...TRUNCATED)	BACKGROUND	"We systematically searched MEDLINE using the Ovid, EMBASE, and Cochrane Library databases without l(...TRUNCATED)	METHODS	"A total of 18 eligible studies, including 14 randomized controlled trials and 4 cohort studies repo(...TRUNCATED)	RESULTS	"Based on the available and low-to-moderate certainty evidence, oral alkali drug therapy might poten(...TRUNCATED)	CONCLUSION	["Acidosis","Administration, Oral","Adult","Alkalies","Cause of Death","Disease Progression","Glomer(...TRUNCATED)	8865123	Introduction	"Metabolic acidosis (MA), a common complication of chronic kidney disease (CKD) caused by failure to(...TRUNCATED)	null	null	Results	"Overview of included trials The literature search yielded 9284 potentially relevant records, of whi(...TRUNCATED)	null	null	["Data sources and search strategy","Study selection and outcome estimation","Data extraction and qu(...TRUNCATED)	["We performed this systematic review according to a pre-specified protocol [9] registered in the In(...TRUNCATED)	[ null, null, null, null, null, null, null, null ]	["Introduction","Materials and methods","Data sources and search strategy","Study selection and outc(...TRUNCATED)	["Metabolic acidosis (MA), a common complication of chronic kidney disease (CKD) caused by failure t(...TRUNCATED)	["intro","materials",null,null,null,null,"results",null,null,null,null,"discussion","supplementary-m(...TRUNCATED)	["Oral alkali drug therapy","pre-dialysis chronic kidney disease","meta-analysis","renal outcomes","(...TRUNCATED)	"Introduction:\nMetabolic acidosis (MA), a common complication of chronic kidney disease (CKD) cause(...TRUNCATED)	"Background:\nMetabolic acidosis accelerates the progression of chronic kidney disease (CKD) and inc(...TRUNCATED)	null	null	8,900	341	[ 178, 237, 250, 424, 316, 541, 240, 51 ]	13	[ "studies", "events", "alkali", "data", "oral", "oral alkali", "egfr", "risk", "included", "therapy" ]	["oral bicarbonate supplementation","bicarbonate supplementation risk","effects alkali supplementati(...TRUNCATED)		null		null		null	"[CONTENT] Oral alkali drug therapy \| pre-dialysis chronic kidney disease \| meta-analysis \| renal ou(...TRUNCATED)	null	"[CONTENT] Oral alkali drug therapy \| pre-dialysis chronic kidney disease \| meta-analysis \| renal ou(...TRUNCATED)	null	"[CONTENT] Oral alkali drug therapy \| pre-dialysis chronic kidney disease \| meta-analysis \| renal ou(...TRUNCATED)	null	"[CONTENT] Acidosis \| Administration, Oral \| Adult \| Alkalies \| Cause of Death \| Disease Progression(...TRUNCATED)	null	"[CONTENT] Acidosis \| Administration, Oral \| Adult \| Alkalies \| Cause of Death \| Disease Progression(...TRUNCATED)	null	"[CONTENT] Acidosis \| Administration, Oral \| Adult \| Alkalies \| Cause of Death \| Disease Progression(...TRUNCATED)	null	"[CONTENT] oral bicarbonate supplementation \| bicarbonate supplementation risk \| effects alkali supp(...TRUNCATED)	null	"[CONTENT] oral bicarbonate supplementation \| bicarbonate supplementation risk \| effects alkali supp(...TRUNCATED)	null	"[CONTENT] oral bicarbonate supplementation \| bicarbonate supplementation risk \| effects alkali supp(...TRUNCATED)	null	"[CONTENT] studies \| events \| alkali \| data \| oral \| oral alkali \| egfr \| risk \| included \| therapy (...TRUNCATED)	null	"[CONTENT] studies \| events \| alkali \| data \| oral \| oral alkali \| egfr \| risk \| included \| therapy (...TRUNCATED)	null	"[CONTENT] studies \| events \| alkali \| data \| oral \| oral alkali \| egfr \| risk \| included \| therapy (...TRUNCATED)	null	"[CONTENT] ckd \| ma \| supplementation \| ckd patients \| patients \| bicarbonate \| mortality \| progress(...TRUNCATED)	null	"[CONTENT] events \| significant \| ci \| table \| heterogeneity \| supplementary \| supplementary table \|(...TRUNCATED)	null	"[CONTENT] studies \| events \| data \| risk \| egfr \| ckd \| alkali \| bias \| oral \| significant [SUMMARY(...TRUNCATED)	null	[CONTENT] \|\|\| \|\|\| [SUMMARY]	null	"[CONTENT] 18 \| 14 \| 4 \| 19 \| 3695 \|\|\| 55% \| 0.45 \| 95% \| CI \| 0.25-0.82 \| 2.59 mL \| 95% \| CI \| 0.(...TRUNCATED)	null	"[CONTENT] \|\|\| \|\|\| \|\|\| MEDLINE \| Ovid \| EMBASE \| Cochrane Library \|\|\| CKD \|\|\| \|\|\| 18 \| 14 \| 4 \| (...TRUNCATED)	null
"Survey about Intention to Engage in Specific Disaster Activities among Disaster Medical Assistance (...TRUNCATED)	34658320	"Different disaster activities should be performed smoothly. In relation to this, human resources fo(...TRUNCATED)	INTRODUCTION	"An anonymous web questionnaire survey was conducted. Japanese DMAT members in the nuclear disaster-(...TRUNCATED)	METHODS	"The intention to engage in C (50), B (47), R/N (58), and E (52) disasters was significantly lower t(...TRUNCATED)	RESULTS	"Experience with a specific type of calamity at a young age may improve intention to engage in not o(...TRUNCATED)	CONCLUSION	["Adult","Disaster Planning","Disasters","Humans","Intention","Medical Assistance","Surveys and Ques(...TRUNCATED)	8607140	Introduction	"In patients with critical conditions, the initial response of the rapid response team or medical em(...TRUNCATED)	Methods	"This was a cross-sectional study. An anonymous web questionnaire survey was conducted from October (...TRUNCATED)	Results	"The characteristics of younger participants in Group A (n = 28), younger participants in Group N (n(...TRUNCATED)	Conclusion	"Japanese DMAT members had a low intention to engage in CBRNE disaster activities compared with natu(...TRUNCATED)	[ "Ethics Committee Approval" ]	["The ethics committee of Fukushima Medical University approved the study protocol (Fukushima, Japan(...TRUNCATED)	[ "other" ]	["Introduction","Methods","Ethics Committee Approval","Results","Discussion","Limitations","Conclusi(...TRUNCATED)	["In patients with critical conditions, the initial response of the rapid response team or medical e(...TRUNCATED)	[ "intro", "methods", "other", "results", "discussion", "other", "conclusions" ]	[ "disaster", "emergency responders", "hazard", "human resources", "intention" ]	"Introduction:\nIn patients with critical conditions, the initial response of the rapid response tea(...TRUNCATED)	"Background:\nDifferent disaster activities should be performed smoothly. In relation to this, human(...TRUNCATED)	"Introduction:\nIn patients with critical conditions, the initial response of the rapid response tea(...TRUNCATED)	"Background:\nDifferent disaster activities should be performed smoothly. In relation to this, human(...TRUNCATED)	5,056	442	[ 24 ]	7	["group","disaster","sd","disasters","eis","engage","nuclear","participants","affected","activities"(...TRUNCATED)	["nuclear disaster activities","firefighters nuclear disaster","disaster medical","radiological nucl(...TRUNCATED)							[CONTENT] disaster \| emergency responders \| hazard \| human resources \| intention [SUMMARY]	[CONTENT] disaster \| emergency responders \| hazard \| human resources \| intention [SUMMARY]	[CONTENT] disaster \| emergency responders \| hazard \| human resources \| intention [SUMMARY]	[CONTENT] disaster \| emergency responders \| hazard \| human resources \| intention [SUMMARY]	[CONTENT] disaster \| emergency responders \| hazard \| human resources \| intention [SUMMARY]	[CONTENT] disaster \| emergency responders \| hazard \| human resources \| intention [SUMMARY]	"[CONTENT] Adult \| Disaster Planning \| Disasters \| Humans \| Intention \| Medical Assistance \| Surveys(...TRUNCATED)	"[CONTENT] Adult \| Disaster Planning \| Disasters \| Humans \| Intention \| Medical Assistance \| Surveys(...TRUNCATED)	"[CONTENT] Adult \| Disaster Planning \| Disasters \| Humans \| Intention \| Medical Assistance \| Surveys(...TRUNCATED)	"[CONTENT] Adult \| Disaster Planning \| Disasters \| Humans \| Intention \| Medical Assistance \| Surveys(...TRUNCATED)	"[CONTENT] Adult \| Disaster Planning \| Disasters \| Humans \| Intention \| Medical Assistance \| Surveys(...TRUNCATED)	"[CONTENT] Adult \| Disaster Planning \| Disasters \| Humans \| Intention \| Medical Assistance \| Surveys(...TRUNCATED)	"[CONTENT] nuclear disaster activities \| firefighters nuclear disaster \| disaster medical \| radiolog(...TRUNCATED)	"[CONTENT] nuclear disaster activities \| firefighters nuclear disaster \| disaster medical \| radiolog(...TRUNCATED)	"[CONTENT] nuclear disaster activities \| firefighters nuclear disaster \| disaster medical \| radiolog(...TRUNCATED)	"[CONTENT] nuclear disaster activities \| firefighters nuclear disaster \| disaster medical \| radiolog(...TRUNCATED)	"[CONTENT] nuclear disaster activities \| firefighters nuclear disaster \| disaster medical \| radiolog(...TRUNCATED)	"[CONTENT] nuclear disaster activities \| firefighters nuclear disaster \| disaster medical \| radiolog(...TRUNCATED)	"[CONTENT] group \| disaster \| sd \| disasters \| eis \| engage \| nuclear \| participants \| affected \| ac(...TRUNCATED)	"[CONTENT] group \| disaster \| sd \| disasters \| eis \| engage \| nuclear \| participants \| affected \| ac(...TRUNCATED)	"[CONTENT] group \| disaster \| sd \| disasters \| eis \| engage \| nuclear \| participants \| affected \| ac(...TRUNCATED)	"[CONTENT] group \| disaster \| sd \| disasters \| eis \| engage \| nuclear \| participants \| affected \| ac(...TRUNCATED)	"[CONTENT] group \| disaster \| sd \| disasters \| eis \| engage \| nuclear \| participants \| affected \| ac(...TRUNCATED)	"[CONTENT] group \| disaster \| sd \| disasters \| eis \| engage \| nuclear \| participants \| affected \| ac(...TRUNCATED)	"[CONTENT] disaster \| response \| activities \| disasters \| disaster activities \| nuclear \| medical \| (...TRUNCATED)	"[CONTENT] area \| affected \| group \| affected area \| disaster \| participants \| non affected area \| n(...TRUNCATED)	"[CONTENT] sd \| group \| 35 \| sd 35 \| older \| participants \| disaster \| younger \| 05 \| participants g(...TRUNCATED)	"[CONTENT] activities \| disaster activities \| disaster \| intention engage cbrne disaster \| intention(...TRUNCATED)	"[CONTENT] disaster \| group \| disasters \| activities \| sd \| disaster activities \| engage \| cbrne \| i(...TRUNCATED)	"[CONTENT] disaster \| group \| disasters \| activities \| sd \| disaster activities \| engage \| cbrne \| i(...TRUNCATED)	[CONTENT] \|\|\| \|\|\| \|\|\| Disaster Medical Assistance Team (DMAT [SUMMARY]	[CONTENT] \|\|\| Japanese \| DMAT \| Group A \| 79 \| Group N \| 99 \|\|\| \|\|\| [SUMMARY]	"[CONTENT] 50 \| R/N \| 58 \| 52 \| 82 \| 82 \|\|\| CBRNE \| age ≤39 years \| Group A \| Group N. By \| Group (...TRUNCATED)	[CONTENT] \|\|\| CBRNE \|\|\| CBRNE \| DMAT [SUMMARY]	"[CONTENT] \|\|\| \|\|\| \|\|\| Disaster Medical Assistance Team (DMAT \|\|\| \|\|\| Japanese \| DMAT \| Group A (...TRUNCATED)	"[CONTENT] \|\|\| \|\|\| \|\|\| Disaster Medical Assistance Team (DMAT \|\|\| \|\|\| Japanese \| DMAT \| Group A (...TRUNCATED)
"Comparison of 4 Methods for Dynamization of Locking Plates: Differences in the Amount and Type of F(...TRUNCATED)	28657927	"Decreasing the stiffness of locked plating constructs can promote natural fracture healing by contr(...TRUNCATED)	BACKGROUND	"Distal femur locking plates were applied to bridge a metadiaphyseal fracture in femur surrogates. A(...TRUNCATED)	METHODS	"Compared with LOCKED control constructs, NONLOCKED constructs had a similar stiffness (P = 0.08), a(...TRUNCATED)	RESULTS	"In a surrogate model of a distal femur fracture, replacing locked with nonlocked diaphyseal screws (...TRUNCATED)	CONCLUSIONS	["Biomechanical Phenomena","Bone Plates","Bone Screws","Diaphyses","Equipment Design","Femoral Fract(...TRUNCATED)	5603978	INTRODUCTION	"Angle-stable locked plating has become the standard treatment for most difficult fractures of the d(...TRUNCATED)	null	null	RESULTS	" Construct Stiffness There was no significant difference between the stiffness of LOCKED control c(...TRUNCATED)	null	null	["Specimens","Loading","Outcome Assessment","Statistical Analysis","Construct Stiffness","Axial Inte(...TRUNCATED)	["Plating constructs were evaluated in fourth generation femur surrogate specimens made of fiber-rei(...TRUNCATED)	[ null, null, null, null, null, null, null ]	["INTRODUCTION","MATERIAL AND METHODS","Specimens","Loading","Outcome Assessment","Statistical Analy(...TRUNCATED)	["Angle-stable locked plating has become the standard treatment for most difficult fractures of the (...TRUNCATED)	["intro","materials\|methods",null,null,null,null,"results",null,null,null,"discussion","supplementar(...TRUNCATED)	["plate fixation","locked plating","dynamization","interfragmentary motion","stiffness","active plat(...TRUNCATED)	"INTRODUCTION:\nAngle-stable locked plating has become the standard treatment for most difficult fra(...TRUNCATED)	"Background:\nDecreasing the stiffness of locked plating constructs can promote natural fracture hea(...TRUNCATED)	null	null	7,145	332	[ 694, 169, 215, 88, 133, 257, 156 ]	12	[ "motion", "group", "plate", "constructs", "locked", "mm", "fracture", "construct", "locking", "cortex" ]	["locked distal femur","fracture healing inhibited","fracture fixation osteopenic","fracture motion (...TRUNCATED)		null		null		null	"[CONTENT] plate fixation \| locked plating \| dynamization \| interfragmentary motion \| stiffness \| ac(...TRUNCATED)	null	"[CONTENT] plate fixation \| locked plating \| dynamization \| interfragmentary motion \| stiffness \| ac(...TRUNCATED)	null	"[CONTENT] plate fixation \| locked plating \| dynamization \| interfragmentary motion \| stiffness \| ac(...TRUNCATED)	null	"[CONTENT] Biomechanical Phenomena \| Bone Plates \| Bone Screws \| Diaphyses \| Equipment Design \| Femo(...TRUNCATED)	null	"[CONTENT] Biomechanical Phenomena \| Bone Plates \| Bone Screws \| Diaphyses \| Equipment Design \| Femo(...TRUNCATED)	null	"[CONTENT] Biomechanical Phenomena \| Bone Plates \| Bone Screws \| Diaphyses \| Equipment Design \| Femo(...TRUNCATED)	null	"[CONTENT] locked distal femur \| fracture healing inhibited \| fracture fixation osteopenic \| fractur(...TRUNCATED)	null	"[CONTENT] locked distal femur \| fracture healing inhibited \| fracture fixation osteopenic \| fractur(...TRUNCATED)	null	"[CONTENT] locked distal femur \| fracture healing inhibited \| fracture fixation osteopenic \| fractur(...TRUNCATED)	null	"[CONTENT] motion \| group \| plate \| constructs \| locked \| mm \| fracture \| construct \| locking \| cort(...TRUNCATED)	null	"[CONTENT] motion \| group \| plate \| constructs \| locked \| mm \| fracture \| construct \| locking \| cort(...TRUNCATED)	null	"[CONTENT] motion \| group \| plate \| constructs \| locked \| mm \| fracture \| construct \| locking \| cort(...TRUNCATED)	null	"[CONTENT] healing \| fracture \| fracture healing \| mechanical \| motion \| plating \| fixation \| dynami(...TRUNCATED)	null	"[CONTENT] group \| 001 \| motion \| group 001 \| greater \| locked control \| control \| locked \| mm \| con(...TRUNCATED)	null	"[CONTENT] motion \| group \| constructs \| locked \| plate \| mm \| fracture \| da \| cortex \| stiffness [S(...TRUNCATED)	null	[CONTENT] \|\|\| 4 [SUMMARY]	null	[CONTENT] NONLOCKED \| 0.08 \| 0.07 \| 0.97 \|\|\| 45% \|\|\| FCL \| 62% \| 75% [SUMMARY]	null	"[CONTENT] \|\|\| 4 \|\|\| \|\|\| \|\|\| Four \| 2 \|\|\| \|\|\| NONLOCKED \| 0.08 \| 0.07 \| 0.97 \|\|\| 45% \|\|\| FCL \| 6(...TRUNCATED)	null
"Efficacy and safety of endoscopic submucosal dissection for gastric tube cancer: A multicenter retr(...TRUNCATED)	33776371	"Recent improvements in the prognosis of patients with esophageal cancer have led to the increased o(...TRUNCATED)	BACKGROUND	"We retrospectively investigated 48 GTC lesions in 38 consecutive patients with GTC in the reconstru(...TRUNCATED)	METHODS	"The median age of patients was 71.5 years (range, 57-84years), and there were 34 men and 4 women. T(...TRUNCATED)	RESULTS	ESD for GTC after esophagectomy was shown to be safe and effective.	CONCLUSION	["Aged","Aged, 80 and over","Dissection","Endoscopic Mucosal Resection","Female","Gastric Mucosa","H(...TRUNCATED)	7985736	INTRODUCTION	"Recently, the survival of patients with esophageal cancer after esophagectomy has improved[1-5]. Ho(...TRUNCATED)	MATERIALS AND METHODS	"Patients We retrospectively investigated patients with GTC in the reconstructed gastric tube after (...TRUNCATED)	null	null	CONCLUSION	"As some patients were observed for only a short time, the assessment of long-term prognosis after E(...TRUNCATED)	["INTRODUCTION","Patients","Endoscopic procedures","Histopathological assessment of curability","Sta(...TRUNCATED)	["Recently, the survival of patients with esophageal cancer after esophagectomy has improved[1-5]. H(...TRUNCATED)	[ null, null, null, null, null, null, null, null, null, null, null, null, null ]	["INTRODUCTION","MATERIALS AND METHODS","Patients","Endoscopic procedures","Histopathological assess(...TRUNCATED)	["Recently, the survival of patients with esophageal cancer after esophagectomy has improved[1-5]. H(...TRUNCATED)	[ null, "methods", null, null, null, null, null, null, null, null, null, null, null, null ]	["Endoscopic submucosal dissection","Gastric tube","Gastric cancer","Eso-phagectomy","Multicenter st(...TRUNCATED)	"INTRODUCTION:\nRecently, the survival of patients with esophageal cancer after esophagectomy has im(...TRUNCATED)	"Background:\nRecent improvements in the prognosis of patients with esophageal cancer have led to th(...TRUNCATED)	"INTRODUCTION:\nRecently, the survival of patients with esophageal cancer after esophagectomy has im(...TRUNCATED)	"Background:\nRecent improvements in the prognosis of patients with esophageal cancer have led to th(...TRUNCATED)	7,384	349	[ 391, 190, 257, 136, 115, 2564, 235, 313, 297, 155, 266, 917, 55 ]	14	["esd","patients","gtc","gastric","submucosal","treatment","endoscopic","cancer","lesions","resectio(...TRUNCATED)	["gtc esophagectomy total","gtc esophagectomy pathological","review gtc esophagectomy","gastric tube(...TRUNCATED)			null				"[CONTENT] Endoscopic submucosal dissection \| Gastric tube \| Gastric cancer \| Eso-phagectomy \| Multi(...TRUNCATED)	"[CONTENT] Endoscopic submucosal dissection \| Gastric tube \| Gastric cancer \| Eso-phagectomy \| Multi(...TRUNCATED)	null	"[CONTENT] Endoscopic submucosal dissection \| Gastric tube \| Gastric cancer \| Eso-phagectomy \| Multi(...TRUNCATED)	"[CONTENT] Endoscopic submucosal dissection \| Gastric tube \| Gastric cancer \| Eso-phagectomy \| Multi(...TRUNCATED)	"[CONTENT] Endoscopic submucosal dissection \| Gastric tube \| Gastric cancer \| Eso-phagectomy \| Multi(...TRUNCATED)	"[CONTENT] Aged \| Aged, 80 and over \| Dissection \| Endoscopic Mucosal Resection \| Female \| Gastric M(...TRUNCATED)	"[CONTENT] Aged \| Aged, 80 and over \| Dissection \| Endoscopic Mucosal Resection \| Female \| Gastric M(...TRUNCATED)	null	"[CONTENT] Aged \| Aged, 80 and over \| Dissection \| Endoscopic Mucosal Resection \| Female \| Gastric M(...TRUNCATED)	"[CONTENT] Aged \| Aged, 80 and over \| Dissection \| Endoscopic Mucosal Resection \| Female \| Gastric M(...TRUNCATED)	"[CONTENT] Aged \| Aged, 80 and over \| Dissection \| Endoscopic Mucosal Resection \| Female \| Gastric M(...TRUNCATED)	"[CONTENT] gtc esophagectomy total \| gtc esophagectomy pathological \| review gtc esophagectomy \| gas(...TRUNCATED)	"[CONTENT] gtc esophagectomy total \| gtc esophagectomy pathological \| review gtc esophagectomy \| gas(...TRUNCATED)	null	"[CONTENT] gtc esophagectomy total \| gtc esophagectomy pathological \| review gtc esophagectomy \| gas(...TRUNCATED)	"[CONTENT] gtc esophagectomy total \| gtc esophagectomy pathological \| review gtc esophagectomy \| gas(...TRUNCATED)	"[CONTENT] gtc esophagectomy total \| gtc esophagectomy pathological \| review gtc esophagectomy \| gas(...TRUNCATED)	"[CONTENT] esd \| patients \| gtc \| gastric \| submucosal \| treatment \| endoscopic \| cancer \| lesions \|(...TRUNCATED)	"[CONTENT] esd \| patients \| gtc \| gastric \| submucosal \| treatment \| endoscopic \| cancer \| lesions \|(...TRUNCATED)	null	"[CONTENT] esd \| patients \| gtc \| gastric \| submucosal \| treatment \| endoscopic \| cancer \| lesions \|(...TRUNCATED)	"[CONTENT] esd \| patients \| gtc \| gastric \| submucosal \| treatment \| endoscopic \| cancer \| lesions \|(...TRUNCATED)	"[CONTENT] esd \| patients \| gtc \| gastric \| submucosal \| treatment \| endoscopic \| cancer \| lesions \|(...TRUNCATED)	"[CONTENT] gtc \| cancer \| esophagectomy \| esd \| resection \| high \| esd gtc \| gastric \| gtc esophagec(...TRUNCATED)	"[CONTENT] knife \| knife knife \| tokyo japan \| japan \| tokyo \| curative \| resection \| study \| ecura (...TRUNCATED)	null	"[CONTENT] significant variability treatment \| accumulation follow cases gtc \| expertise accumulatio(...TRUNCATED)	"[CONTENT] esd \| patients \| gtc \| knife \| gastric \| resection \| lesions \| submucosal \| treatment \| c(...TRUNCATED)	"[CONTENT] esd \| patients \| gtc \| knife \| gastric \| resection \| lesions \| submucosal \| treatment \| c(...TRUNCATED)	[CONTENT] GTC \|\|\| ESD \| GTC [SUMMARY]	"[CONTENT] 48 \| GTC \| 38 \| GTC \| ESD \| between January 2005 \| December 2019 \| 8 \|\|\| ESD \| GTC \|\|\| ES(...TRUNCATED)	null	[CONTENT] ESD \| GTC [SUMMARY]	"[CONTENT] GTC \|\|\| ESD \| GTC \|\|\| 48 \| GTC \| 38 \| GTC \| ESD \| between January 2005 \| December 2019 \| (...TRUNCATED)	"[CONTENT] GTC \|\|\| ESD \| GTC \|\|\| 48 \| GTC \| 38 \| GTC \| ESD \| between January 2005 \| December 2019 \| (...TRUNCATED)
"OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemoth(...TRUNCATED)	25611302	"Treatment of advanced and metastatic colorectal cancer with irinotecan is hampered by severe toxici(...TRUNCATED)	BACKGROUND	"Blood samples (n=127) and tumour tissue (n=30) were obtained from advanced cancer patients treated (...TRUNCATED)	METHODS	"SLCO1B1 521C was significantly associated with increased SN-38 exposure (P<0.001), which was additi(...TRUNCATED)	RESULTS	"Clarifying the association of host genetic variation in OATP and ABC transporters to SN-38 exposure(...TRUNCATED)	CONCLUSIONS	["Adult","Aged","Aged, 80 and over","Antineoplastic Agents, Phytogenic","Camptothecin","Colorectal N(...TRUNCATED)	4453959	null	null	null	null	Results	" Study population Patient and tumour characteristics (n=127) are described in Table 1. The treatme(...TRUNCATED)	null	null	["Study population","Chart review","Genotyping","Drug levels","Immunohistochemistry","Statistics","S(...TRUNCATED)	["Metastatic colorectal cancer and advanced or metastatic pancreatic cancer patients (n=127) being t(...TRUNCATED)	[ null, null, null, null, null, null, null, null, null, null, null ]	["Materials and Methods","Study population","Chart review","Genotyping","Drug levels","Immunohistoch(...TRUNCATED)	[" Study population Metastatic colorectal cancer and advanced or metastatic pancreatic cancer patie(...TRUNCATED)	[ "materials\|methods", null, null, null, null, null, null, "results", null, null, null, null, null, "discussion" ]	[ "OATP1B1", "OATP1B3", "Irinotecan", "SN-38", "colorectal cancer" ]	"Materials and Methods:\n Study population Metastatic colorectal cancer and advanced or metastatic (...TRUNCATED)	"Background:\nTreatment of advanced and metastatic colorectal cancer with irinotecan is hampered by (...TRUNCATED)	null	null	10,545	266	[ 172, 263, 191, 350, 192, 443, 68, 507, 314, 206, 202 ]	14	[ "patients", "11", "cpt 11", "cpt", "sn", "38", "sn 38", "grade", "analysis", "28" ]	["chemotherapy regimens scored","chemotherapy majority patients","folfiri chemotherapy regimens","me(...TRUNCATED)	null	null		null		null	null	null	[CONTENT] OATP1B1 \| OATP1B3 \| Irinotecan \| SN-38 \| colorectal cancer [SUMMARY]	null	[CONTENT] OATP1B1 \| OATP1B3 \| Irinotecan \| SN-38 \| colorectal cancer [SUMMARY]	null	null	null	"[CONTENT] Adult \| Aged \| Aged, 80 and over \| Antineoplastic Agents, Phytogenic \| Camptothecin \| Col(...TRUNCATED)	null	"[CONTENT] Adult \| Aged \| Aged, 80 and over \| Antineoplastic Agents, Phytogenic \| Camptothecin \| Col(...TRUNCATED)	null	null	null	"[CONTENT] chemotherapy regimens scored \| chemotherapy majority patients \| folfiri chemotherapy regi(...TRUNCATED)	null	"[CONTENT] chemotherapy regimens scored \| chemotherapy majority patients \| folfiri chemotherapy regi(...TRUNCATED)	null	null	null	[CONTENT] patients \| 11 \| cpt 11 \| cpt \| sn \| 38 \| sn 38 \| grade \| analysis \| 28 [SUMMARY]	null	[CONTENT] patients \| 11 \| cpt 11 \| cpt \| sn \| 38 \| sn 38 \| grade \| analysis \| 28 [SUMMARY]	null	null	null	"[CONTENT] patients \| sn \| 95 \| table \| ci \| 95 ci \| significantly \| levels \| 28 \| compared [SUMMARY(...TRUNCATED)	null	[CONTENT] patients \| 11 \| cpt \| cpt 11 \| sn \| table \| grade \| oatp1b3 \| 95 \| analysis [SUMMARY]	null	null	null	"[CONTENT] 521C \| 28 \|\|\| ABCC5 \| rs562 \| SN-38 \| APC \|\|\| ABCC2-24C/T \| 0.06-0.85 \| CES1 \| OR=0.29 \| (...TRUNCATED)	null	"[CONTENT] irinotecan \|\|\| irinotecan \| SN-38 \| ABC \|\|\| irinotecan \|\|\| \|\|\| \|\|\| 521C \| 28 \|\|\| ABCC5 (...TRUNCATED)	null
"A model to explain the challenges of emergency medical technicians' decision making process in emer(...TRUNCATED)	35067498	"To manage life-threatening conditions and reduce morbidity and mortality, pre-hospital's on-scene d(...TRUNCATED)	BACKGROUND	"This study was applied through grounded theory method using direct field observations and semi-stru(...TRUNCATED)	METHODS	"A paradigm model was developed to explain the relationships among the main categories. Decision mak(...TRUNCATED)	RESULTS	"Based on the finding of this study, Emergency Medical technicians' decision making in the context o(...TRUNCATED)	CONCLUSIONS	["Decision Making","Emergency Medical Services","Emergency Medical Technicians","Grounded Theory","H(...TRUNCATED)	9115813	Introduction	"Emergency Medical Services (EMS) centers were established to provide on-time and rapid services to (...TRUNCATED)	Methods	"\nStudy setting\n\nIn Iran, national EMS system provides free services for patients and injured peo(...TRUNCATED)	Results	"This study explored the EMTS 'on-scene decision making process. In the initial analysis, 1352 codes(...TRUNCATED)	Conclusion	"This study designed a paradigm model to explain the process and to explore the relationships betwee(...TRUNCATED)	[]	[]	[]	[ "Introduction", "Methods ", "Results", "Discussion", "Conclusion" ]	["Emergency Medical Services (EMS) centers were established to provide on-time and rapid services to(...TRUNCATED)	[ "introduction", "methods", "results", "discussion", "conclusion" ]	["Emergency medical services","Emergency medical technician","Decision making","Pre-hospital","Iran (...TRUNCATED)	"Introduction:\nEmergency Medical Services (EMS) centers were established to provide on-time and rap(...TRUNCATED)	"Background:\nTo manage life-threatening conditions and reduce morbidity and mortality, pre-hospital(...TRUNCATED)	"Introduction:\nEmergency Medical Services (EMS) centers were established to provide on-time and rap(...TRUNCATED)	"Background:\nTo manage life-threatening conditions and reduce morbidity and mortality, pre-hospital(...TRUNCATED)	5,613	348	[]	5	["emts","decision","making","decision making","scene","emergency","medical","hospital","study","pati(...TRUNCATED)	["effect emts decisions","emergency care concluded","services emts emergency","emt decision making",(...TRUNCATED)							"[CONTENT] Emergency medical services \| Emergency medical technician \| Decision making \| Pre-hospita(...TRUNCATED)	"[CONTENT] Emergency medical services \| Emergency medical technician \| Decision making \| Pre-hospita(...TRUNCATED)	"[CONTENT] Emergency medical services \| Emergency medical technician \| Decision making \| Pre-hospita(...TRUNCATED)	"[CONTENT] Emergency medical services \| Emergency medical technician \| Decision making \| Pre-hospita(...TRUNCATED)	"[CONTENT] Emergency medical services \| Emergency medical technician \| Decision making \| Pre-hospita(...TRUNCATED)	"[CONTENT] Emergency medical services \| Emergency medical technician \| Decision making \| Pre-hospita(...TRUNCATED)	"[CONTENT] Decision Making \| Emergency Medical Services \| Emergency Medical Technicians \| Grounded T(...TRUNCATED)	"[CONTENT] Decision Making \| Emergency Medical Services \| Emergency Medical Technicians \| Grounded T(...TRUNCATED)	"[CONTENT] Decision Making \| Emergency Medical Services \| Emergency Medical Technicians \| Grounded T(...TRUNCATED)	"[CONTENT] Decision Making \| Emergency Medical Services \| Emergency Medical Technicians \| Grounded T(...TRUNCATED)	"[CONTENT] Decision Making \| Emergency Medical Services \| Emergency Medical Technicians \| Grounded T(...TRUNCATED)	"[CONTENT] Decision Making \| Emergency Medical Services \| Emergency Medical Technicians \| Grounded T(...TRUNCATED)	"[CONTENT] effect emts decisions \| emergency care concluded \| services emts emergency \| emt decision(...TRUNCATED)	"[CONTENT] effect emts decisions \| emergency care concluded \| services emts emergency \| emt decision(...TRUNCATED)	"[CONTENT] effect emts decisions \| emergency care concluded \| services emts emergency \| emt decision(...TRUNCATED)	"[CONTENT] effect emts decisions \| emergency care concluded \| services emts emergency \| emt decision(...TRUNCATED)	"[CONTENT] effect emts decisions \| emergency care concluded \| services emts emergency \| emt decision(...TRUNCATED)	"[CONTENT] effect emts decisions \| emergency care concluded \| services emts emergency \| emt decision(...TRUNCATED)	"[CONTENT] emts \| decision \| making \| decision making \| scene \| emergency \| medical \| hospital \| stu(...TRUNCATED)	"[CONTENT] emts \| decision \| making \| decision making \| scene \| emergency \| medical \| hospital \| stu(...TRUNCATED)	"[CONTENT] emts \| decision \| making \| decision making \| scene \| emergency \| medical \| hospital \| stu(...TRUNCATED)	"[CONTENT] emts \| decision \| making \| decision making \| scene \| emergency \| medical \| hospital \| stu(...TRUNCATED)	"[CONTENT] emts \| decision \| making \| decision making \| scene \| emergency \| medical \| hospital \| stu(...TRUNCATED)	"[CONTENT] emts \| decision \| making \| decision making \| scene \| emergency \| medical \| hospital \| stu(...TRUNCATED)	"[CONTENT] decision \| scene \| making \| decision making \| emts \| morbidity \| mortality \| morbidity mo(...TRUNCATED)	"[CONTENT] interviews \| data \| categories \| data collection \| collection \| field \| pi \| ems \| center(...TRUNCATED)	"[CONTENT] emts \| decision \| trust \| making \| patient \| decision making \| hospital \| patients \| emer(...TRUNCATED)	"[CONTENT] emts \| medical \| study \| model \| decision \| decision making \| process \| emergency \| makin(...TRUNCATED)	"[CONTENT] emts \| decision \| making \| decision making \| scene \| emergency \| medical \| study \| hospit(...TRUNCATED)	"[CONTENT] emts \| decision \| making \| decision making \| scene \| emergency \| medical \| study \| hospit(...TRUNCATED)	[CONTENT] \|\|\| \|\|\| Iranian [SUMMARY]	[CONTENT] \|\|\| 26 \| 17 \| 1 \|\|\| Interviews \| October 2018 to July 2019 \|\|\| Strauss \| 2015 [SUMMARY]	[CONTENT] \|\|\| \|\|\| \|\|\| \|\|\| Emergency Medical [SUMMARY]	"[CONTENT] Emergency Medical \| the Emergency Medical Technicians \|\|\| the Emergency Medical Technicia(...TRUNCATED)	"[CONTENT] \|\|\| \|\|\| Iranian \|\|\| \|\|\| 26 \| 17 \| 1 \|\|\| Interviews \| October 2018 to July 2019 \|\|\| Str(...TRUNCATED)	"[CONTENT] \|\|\| \|\|\| Iranian \|\|\| \|\|\| 26 \| 17 \| 1 \|\|\| Interviews \| October 2018 to July 2019 \|\|\| Str(...TRUNCATED)
Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score.	35092368	"The objective of this study was to develop a diagnostic prediction model for diagnosis of malignant(...TRUNCATED)	BACKGROUND	"Retrospective analysis of pleural fluid cytology was conducted in patients with MPE between 2018 an(...TRUNCATED)	MATERIALS AND METHODS	"The data of pleural fluid cytology from 155 MPE patients were analyzed. Seventy-eight positive pleu(...TRUNCATED)	RESULTS	"The MPE score, as the diagnostic prediction model can be used in planning for more efficient diagno(...TRUNCATED)	CONCLUSIONS	["Adult","Area Under Curve","Biomarkers, Tumor","Body Fluids","Clinical Decision Rules","Female","Hu(...TRUNCATED)	9258676	Introduction	"Malignant pleural effusion (MPE) refers to finding cytology pleural fluid caused by the metastasis (...TRUNCATED)	null	null	Results	"The data of the cytologic results of pleural fluid of 166 patients were collected. Eleven patients (...TRUNCATED)	null	null	[ "Author Contribution Statement", "Funding Statement" ]	["Chaichana Chantharakhit: Designed the study, reviewed the paper, collected data, analyzed data, an(...TRUNCATED)	[ null, null ]	["Introduction","Materials and Methods","Results","Discussion","Author Contribution Statement","Fund(...TRUNCATED)	["Malignant pleural effusion (MPE) refers to finding cytology pleural fluid caused by the metastasis(...TRUNCATED)	[ "intro", "materials\|methods", "results", "discussion", null, null, "data-availability" ]	[ "MPE score", "pleural fluid cytology", "diagnostic prediction model", "malignant pleural effusion" ]	"Introduction:\nMalignant pleural effusion (MPE) refers to finding cytology pleural fluid caused by (...TRUNCATED)	"Background:\nThe objective of this study was to develop a diagnostic prediction model for diagnosis(...TRUNCATED)	null	null	2,951	327	[ 38, 25 ]	7	[ "pleural", "mpe", "fluid", "pleural fluid", "cancer", "diagnosis", "data", "cytology", "score", "ratio" ]	["diagnosis mpe cytology","mpe improved pleuroscopy","cytology pleural effusion","mpe pleural fluid"(...TRUNCATED)		null		null		null	"[CONTENT] MPE score \| pleural fluid cytology \| diagnostic prediction model \| malignant pleural effu(...TRUNCATED)	null	"[CONTENT] MPE score \| pleural fluid cytology \| diagnostic prediction model \| malignant pleural effu(...TRUNCATED)	null	"[CONTENT] MPE score \| pleural fluid cytology \| diagnostic prediction model \| malignant pleural effu(...TRUNCATED)	null	"[CONTENT] Adult \| Area Under Curve \| Biomarkers, Tumor \| Body Fluids \| Clinical Decision Rules \| Fe(...TRUNCATED)	null	"[CONTENT] Adult \| Area Under Curve \| Biomarkers, Tumor \| Body Fluids \| Clinical Decision Rules \| Fe(...TRUNCATED)	null	"[CONTENT] Adult \| Area Under Curve \| Biomarkers, Tumor \| Body Fluids \| Clinical Decision Rules \| Fe(...TRUNCATED)	null	"[CONTENT] diagnosis mpe cytology \| mpe improved pleuroscopy \| cytology pleural effusion \| mpe pleur(...TRUNCATED)	null	"[CONTENT] diagnosis mpe cytology \| mpe improved pleuroscopy \| cytology pleural effusion \| mpe pleur(...TRUNCATED)	null	"[CONTENT] diagnosis mpe cytology \| mpe improved pleuroscopy \| cytology pleural effusion \| mpe pleur(...TRUNCATED)	null	"[CONTENT] pleural \| mpe \| fluid \| pleural fluid \| cancer \| diagnosis \| data \| cytology \| score \| ra(...TRUNCATED)	null	"[CONTENT] pleural \| mpe \| fluid \| pleural fluid \| cancer \| diagnosis \| data \| cytology \| score \| ra(...TRUNCATED)	null	"[CONTENT] pleural \| mpe \| fluid \| pleural fluid \| cancer \| diagnosis \| data \| cytology \| score \| ra(...TRUNCATED)	null	"[CONTENT] mpe \| cancer \| pleural \| cytology \| diagnostic \| diagnosis \| invasive \| method \| fluid \| (...TRUNCATED)	null	"[CONTENT] equal \| score \| mpe \| curve \| value \| logistic regression \| logistic \| regression \| ratio(...TRUNCATED)	null	"[CONTENT] pleural \| mpe \| fluid \| pleural fluid \| financial \| data \| cancer \| diagnosis \| cytology (...TRUNCATED)	null	[CONTENT] MPE \| pleural fluid \| MPE [SUMMARY]	null	"[CONTENT] pleural fluid \| 155 \| MPE \|\|\| Seventy-eight \| 50.32% \|\|\| 66.67% \|\|\| 4.64 \| 555 \|\|\| 60 \| d(...TRUNCATED)	null	"[CONTENT] MPE \| pleural fluid \| MPE \|\|\| MPE \| between 2018 and 2020 \|\|\| \|\|\| \|\|\| \|\|\| \|\|\| pleural(...TRUNCATED)	null
A deep neural network using audio files for detection of aortic stenosis.	35438211	"Although aortic stenosis (AS) is the most common valvular heart disease in the western world, many (...TRUNCATED)	BACKGROUND	"A deep neural network (DNN) was trained by preprocessed audio files of 100 patients with AS and 100(...TRUNCATED)	METHODS	"Eighteen percent of patients without AS and 22% of patients with AS showed an additional moderate o(...TRUNCATED)	RESULTS	"The present study shows that deep learning-guided auscultation predicts significant AS with similar(...TRUNCATED)	CONCLUSIONS	["Aortic Valve Stenosis","Cardiologists","Cardiology","Humans","Neural Networks, Computer","Pilot Pr(...TRUNCATED)	9175247	BACKGROUND	"After mitral regurgitation, aortic valve stenosis (AS) is the second most common valvular disease.\(...TRUNCATED)	METHODS	"The study consists of two parts. In the first part, we trained a neural network to classify auscult(...TRUNCATED)	RESULTS	"Data from 120 patients with and 120 patients without AS were taken for the present study. From each(...TRUNCATED)	null	null	["DNN's diagnostic accuracy","Diagnostic accuracy of the CNN versus cardiologists, residents, and st(...TRUNCATED)	["Hyperparameter tuning was done using K‐fold cross‐validation. The training data were split int(...TRUNCATED)	[ null, null, null ]	["BACKGROUND","METHODS","RESULTS","DNN's diagnostic accuracy","Diagnostic accuracy of the CNN versus(...TRUNCATED)	["After mitral regurgitation, aortic valve stenosis (AS) is the second most common valvular disease.(...TRUNCATED)	[ "background", "methods", "results", null, null, "discussion", null, "COI-statement" ]	["aortic stenosis","artificial intelligence","auscultation","deep neural network","machine learning"(...TRUNCATED)	"BACKGROUND:\nAfter mitral regurgitation, aortic valve stenosis (AS) is the second most common valvu(...TRUNCATED)	"Background:\nAlthough aortic stenosis (AS) is the most common valvular heart disease in the western(...TRUNCATED)	null	null	4,795	268	[ 389, 264, 90 ]	8	["auscultation","dnn","patients","data","cardiologists","residents","students","audio","files","audi(...TRUNCATED)	["valve stenosis second","aortic valve replacement","stenosis patients valvular","aortic stenosis fa(...TRUNCATED)				null		null	"[CONTENT] aortic stenosis \| artificial intelligence \| auscultation \| deep neural network \| machine (...TRUNCATED)	"[CONTENT] aortic stenosis \| artificial intelligence \| auscultation \| deep neural network \| machine (...TRUNCATED)	"[CONTENT] aortic stenosis \| artificial intelligence \| auscultation \| deep neural network \| machine (...TRUNCATED)	null	"[CONTENT] aortic stenosis \| artificial intelligence \| auscultation \| deep neural network \| machine (...TRUNCATED)	null	"[CONTENT] Aortic Valve Stenosis \| Cardiologists \| Cardiology \| Humans \| Neural Networks, Computer \|(...TRUNCATED)	"[CONTENT] Aortic Valve Stenosis \| Cardiologists \| Cardiology \| Humans \| Neural Networks, Computer \|(...TRUNCATED)	"[CONTENT] Aortic Valve Stenosis \| Cardiologists \| Cardiology \| Humans \| Neural Networks, Computer \|(...TRUNCATED)	null	"[CONTENT] Aortic Valve Stenosis \| Cardiologists \| Cardiology \| Humans \| Neural Networks, Computer \|(...TRUNCATED)	null	"[CONTENT] valve stenosis second \| aortic valve replacement \| stenosis patients valvular \| aortic st(...TRUNCATED)	"[CONTENT] valve stenosis second \| aortic valve replacement \| stenosis patients valvular \| aortic st(...TRUNCATED)	"[CONTENT] valve stenosis second \| aortic valve replacement \| stenosis patients valvular \| aortic st(...TRUNCATED)	null	"[CONTENT] valve stenosis second \| aortic valve replacement \| stenosis patients valvular \| aortic st(...TRUNCATED)	null	"[CONTENT] auscultation \| dnn \| patients \| data \| cardiologists \| residents \| students \| audio \| fil(...TRUNCATED)	"[CONTENT] auscultation \| dnn \| patients \| data \| cardiologists \| residents \| students \| audio \| fil(...TRUNCATED)	"[CONTENT] auscultation \| dnn \| patients \| data \| cardiologists \| residents \| students \| audio \| fil(...TRUNCATED)	null	"[CONTENT] auscultation \| dnn \| patients \| data \| cardiologists \| residents \| students \| audio \| fil(...TRUNCATED)	null	"[CONTENT] population \| heart \| significant \| valve \| years \| 65 \| replacement \| mortality \| valve r(...TRUNCATED)	"[CONTENT] files \| auscultation \| audio \| patients \| data \| 10 \| test \| coefficients \| mfcc \| convol(...TRUNCATED)	"[CONTENT] students \| residents \| dnn \| cardiologists \| patients \| point \| auscultation \| 94 \| 93 \| (...TRUNCATED)	null	"[CONTENT] auscultation \| dnn \| students \| patients \| data \| residents \| cardiologists \| files \| aud(...TRUNCATED)	null	[CONTENT] \|\|\| \|\|\| [SUMMARY]	[CONTENT] 100 \| AS and 100 \|\|\| 40 \|\|\| F1 \|\|\| [SUMMARY]	"[CONTENT] Eighteen percent \| 22% \|\|\| 0.90 \| 0.81 \| 1 \| F1 \| 0.95 \| 0.89-1.0 \|\|\| F1 \| 0.94 \| 0.86-1.(...TRUNCATED)	null	"[CONTENT] \|\|\| \|\|\| \|\|\| 100 \| AS and 100 \|\|\| 40 \|\|\| F1 \|\|\| \|\|\| Eighteen percent \| 22% \|\|\| 0.90 \| (...TRUNCATED)	null
"Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and (...TRUNCATED)	25618747	"Loss-of-function mutations in the skin barrier protein filaggrin (FLG) are a major risk for atopic (...TRUNCATED)	BACKGROUND	"A total of 1903 infants were enrolled in the Cork Babies After Scope: Evaluating the Longitudinal I(...TRUNCATED)	METHODS	"At 6 months, 18.7% of the children had AD, and at 12 months, 15.53%. In a logistic regression model(...TRUNCATED)	RESULTS	"Impairment of skin barrier function at birth and at 2 months precedes clinical AD. In addition to p(...TRUNCATED)	CONCLUSIONS	["DNA Mutational Analysis","Dermatitis, Atopic","Female","Filaggrin Proteins","Genotype","Humans","I(...TRUNCATED)	4382348	null	null	Methods	" Study subjects The Cork Babies After Scope: Evaluating the Longitudinal Impact Using Neurological(...TRUNCATED)	Results	"A total of 1903 infants were enrolled onto the study. The demographic details of the population stu(...TRUNCATED)	null	null	["Study subjects","TEWL measurements","Statistical analysis","Filaggrin mutation typing","TEWL throu(...TRUNCATED)	["The Cork Babies After Scope: Evaluating the Longitudinal Impact Using Neurological and Nutritional(...TRUNCATED)	[ null, null, null, null, null, null, null, null, null ]	["Methods","Study subjects","TEWL measurements","Statistical analysis","Results","Filaggrin mutation(...TRUNCATED)	[" Study subjects The Cork Babies After Scope: Evaluating the Longitudinal Impact Using Neurologica(...TRUNCATED)	[ "methods", null, null, null, "results", null, null, null, null, null, null, "discussion" ]	["Infant","skin barrier","TEWL","atopic dermatitis","filaggrin","predictor","biomarker","AD, Atopic (...TRUNCATED)	"Methods:\n Study subjects The Cork Babies After Scope: Evaluating the Longitudinal Impact Using Ne(...TRUNCATED)	"Background:\nLoss-of-function mutations in the skin barrier protein filaggrin (FLG) are a major ris(...TRUNCATED)	null	null	7,641	401	[ 370, 248, 338, 84, 165, 123, 311, 226, 292 ]	12	[ "months", "tewl", "ad", "flg", "12", "infants", "12 months", "model", "mutation", "flg mutation" ]	["term infant postnatal","cork university maternity","birth cohort study","cork baseline birth","inf(...TRUNCATED)	null			null		null	null	"[CONTENT] Infant \| skin barrier \| TEWL \| atopic dermatitis \| filaggrin \| predictor \| biomarker \| AD(...TRUNCATED)	"[CONTENT] Infant \| skin barrier \| TEWL \| atopic dermatitis \| filaggrin \| predictor \| biomarker \| AD(...TRUNCATED)	null	"[CONTENT] Infant \| skin barrier \| TEWL \| atopic dermatitis \| filaggrin \| predictor \| biomarker \| AD(...TRUNCATED)	null	null	"[CONTENT] DNA Mutational Analysis \| Dermatitis, Atopic \| Female \| Filaggrin Proteins \| Genotype \| H(...TRUNCATED)	"[CONTENT] DNA Mutational Analysis \| Dermatitis, Atopic \| Female \| Filaggrin Proteins \| Genotype \| H(...TRUNCATED)	null	"[CONTENT] DNA Mutational Analysis \| Dermatitis, Atopic \| Female \| Filaggrin Proteins \| Genotype \| H(...TRUNCATED)	null	null	"[CONTENT] term infant postnatal \| cork university maternity \| birth cohort study \| cork baseline bi(...TRUNCATED)	"[CONTENT] term infant postnatal \| cork university maternity \| birth cohort study \| cork baseline bi(...TRUNCATED)	null	"[CONTENT] term infant postnatal \| cork university maternity \| birth cohort study \| cork baseline bi(...TRUNCATED)	null	null	"[CONTENT] months \| tewl \| ad \| flg \| 12 \| infants \| 12 months \| model \| mutation \| flg mutation [SU(...TRUNCATED)	"[CONTENT] months \| tewl \| ad \| flg \| 12 \| infants \| 12 months \| model \| mutation \| flg mutation [SU(...TRUNCATED)	null	"[CONTENT] months \| tewl \| ad \| flg \| 12 \| infants \| 12 months \| model \| mutation \| flg mutation [SU(...TRUNCATED)	null	null	"[CONTENT] months \| study \| recruited \| birth \| cork \| 12 \| room \| variable \| scope \| tewl [SUMMARY](...TRUNCATED)	"[CONTENT] tewl \| months \| model \| flg \| ad \| mutation \| infants \| day \| flg mutation \| month [SUMMA(...TRUNCATED)	null	"[CONTENT] months \| tewl \| ad \| flg \| infants \| model \| 12 \| mutation \| flg mutation \| 12 months [SU(...TRUNCATED)	null	null	"[CONTENT] 1903 \| the Cork Babies After Scope: Evaluating the Longitudinal Impact Using Neurological(...TRUNCATED)	"[CONTENT] 6 months \| 18.7% \| 12 months \| 15.53% \|\|\| day 2 \| TEWL \| 12 months \| 0.81 \|\|\| day 2 \| TEW(...TRUNCATED)	null	"[CONTENT] FLG \|\|\| \|\|\| \|\|\| \|\|\| 1903 \| the Cork Babies After Scope: Evaluating the Longitudinal Im(...TRUNCATED)	null
"In vitro antioxidant and anticancer effects of solvent fractions from Prunella vulgaris var. lilaci(...TRUNCATED)	24206840	"Recently, considerable attention has been focused on exploring the potential antioxidant properties(...TRUNCATED)	BACKGROUND	"Dried powder of P. vulgaris var. lilacina was extracted with ethanol, and the extract was fractiona(...TRUNCATED)	METHODS	"The total phenolic contents of the ethanol extract and water fraction of P. vulgaris var. lilacina (...TRUNCATED)	RESULTS	"These results suggest that the ethanol extract from P. vulgaris var. lilacina and its fractions cou(...TRUNCATED)	CONCLUSIONS	["Analysis of Variance","Animals","Antineoplastic Agents","Antioxidants","Cell Line, Tumor","Cell Su(...TRUNCATED)	4226201	Background	"Oxidative stress is caused by reactive oxygen species (ROS), which are associated with many patholo(...TRUNCATED)	Methods	" Reagents The reagents 1,1-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azinibis 3-ethyl benzothiazoli(...TRUNCATED)	null	null	Conclusions	"The present study determined that P. vulgaris var. lilacina extract and its fractions have strong a(...TRUNCATED)	["Background","Reagents","Sample preparation and extraction","Total phenolic content","DPPH radical (...TRUNCATED)	["Oxidative stress is caused by reactive oxygen species (ROS), which are associated with many pathol(...TRUNCATED)	[null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null(...TRUNCATED)	["Background","Methods","Reagents","Sample preparation and extraction","Total phenolic content","DPP(...TRUNCATED)	["Oxidative stress is caused by reactive oxygen species (ROS), which are associated with many pathol(...TRUNCATED)	[null,"methods",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null(...TRUNCATED)	[ "Prunella vulgaris var. lilacina", "Antioxidative activity", "Anticancer activity" ]	"Background:\nOxidative stress is caused by reactive oxygen species (ROS), which are associated with(...TRUNCATED)	"Background:\nRecently, considerable attention has been focused on exploring the potential antioxida(...TRUNCATED)	"Background:\nOxidative stress is caused by reactive oxygen species (ROS), which are associated with(...TRUNCATED)	"Background:\nRecently, considerable attention has been focused on exploring the potential antioxida(...TRUNCATED)	13,736	452	[ 351, 154, 188, 123, 170, 93, 145, 116, 87, 97, 78, 247, 144, 76, 5083, 38, 234, 770, 182, 940, 355, 78, 10, 58, 16 ]	28	["vulgaris var","var lilacina","var","lilacina","vulgaris","vulgaris var lilacina","extract","activi(...TRUNCATED)	["strong antioxidant activity","antioxidants especially plant","antioxidants vulgaris","extracts hig(...TRUNCATED)			null				[CONTENT] Prunella vulgaris var. lilacina \| Antioxidative activity \| Anticancer activity [SUMMARY]	[CONTENT] Prunella vulgaris var. lilacina \| Antioxidative activity \| Anticancer activity [SUMMARY]	null	[CONTENT] Prunella vulgaris var. lilacina \| Antioxidative activity \| Anticancer activity [SUMMARY]	[CONTENT] Prunella vulgaris var. lilacina \| Antioxidative activity \| Anticancer activity [SUMMARY]	[CONTENT] Prunella vulgaris var. lilacina \| Antioxidative activity \| Anticancer activity [SUMMARY]	"[CONTENT] Analysis of Variance \| Animals \| Antineoplastic Agents \| Antioxidants \| Cell Line, Tumor (...TRUNCATED)	"[CONTENT] Analysis of Variance \| Animals \| Antineoplastic Agents \| Antioxidants \| Cell Line, Tumor (...TRUNCATED)	null	"[CONTENT] Analysis of Variance \| Animals \| Antineoplastic Agents \| Antioxidants \| Cell Line, Tumor (...TRUNCATED)	"[CONTENT] Analysis of Variance \| Animals \| Antineoplastic Agents \| Antioxidants \| Cell Line, Tumor (...TRUNCATED)	"[CONTENT] Analysis of Variance \| Animals \| Antineoplastic Agents \| Antioxidants \| Cell Line, Tumor (...TRUNCATED)	"[CONTENT] strong antioxidant activity \| antioxidants especially plant \| antioxidants vulgaris \| ext(...TRUNCATED)	"[CONTENT] strong antioxidant activity \| antioxidants especially plant \| antioxidants vulgaris \| ext(...TRUNCATED)	null	"[CONTENT] strong antioxidant activity \| antioxidants especially plant \| antioxidants vulgaris \| ext(...TRUNCATED)	"[CONTENT] strong antioxidant activity \| antioxidants especially plant \| antioxidants vulgaris \| ext(...TRUNCATED)	"[CONTENT] strong antioxidant activity \| antioxidants especially plant \| antioxidants vulgaris \| ext(...TRUNCATED)	"[CONTENT] vulgaris var \| var lilacina \| var \| lilacina \| vulgaris \| vulgaris var lilacina \| extract(...TRUNCATED)	"[CONTENT] vulgaris var \| var lilacina \| var \| lilacina \| vulgaris \| vulgaris var lilacina \| extract(...TRUNCATED)	null	"[CONTENT] vulgaris var \| var lilacina \| var \| lilacina \| vulgaris \| vulgaris var lilacina \| extract(...TRUNCATED)	"[CONTENT] vulgaris var \| var lilacina \| var \| lilacina \| vulgaris \| vulgaris var lilacina \| extract(...TRUNCATED)	"[CONTENT] vulgaris var \| var lilacina \| var \| lilacina \| vulgaris \| vulgaris var lilacina \| extract(...TRUNCATED)	"[CONTENT] antioxidants \| anti \| oxidative \| antioxidant \| vulgaris \| var lilacina \| var \| vulgaris (...TRUNCATED)	"[CONTENT] solution \| absorbance \| line \| cell line \| cell \| min \| radical \| cells \| reverse \| usa [(...TRUNCATED)	null	"[CONTENT] antioxidant \| anticancer \| vulgaris \| var lilacina \| var \| vulgaris var lilacina \| vulgar(...TRUNCATED)	"[CONTENT] vulgaris \| lilacina \| var lilacina \| vulgaris var lilacina \| var \| vulgaris var \| extract(...TRUNCATED)	"[CONTENT] vulgaris \| lilacina \| var lilacina \| vulgaris var lilacina \| var \| vulgaris var \| extract(...TRUNCATED)	"[CONTENT] \|\|\| \|\|\| Korea \| Japan \| China \| Europe \|\|\| P. vulgaris var \|\|\| \|\|\| P. vulgaris var \|\|\|(...TRUNCATED)	[CONTENT] \|\|\| the hexane fraction \|\|\| Folin \|\|\| FRAP \| ABTS \| SOD \|\|\| MTT \|\|\| RT-PCR [SUMMARY]	null	[CONTENT] P. vulgaris var \|\|\| [SUMMARY]	"[CONTENT] \|\|\| \|\|\| Korea \| Japan \| China \| Europe \|\|\| P. vulgaris var \|\|\| \|\|\| P. vulgaris var \|\|\|(...TRUNCATED)	"[CONTENT] \|\|\| \|\|\| Korea \| Japan \| China \| Europe \|\|\| P. vulgaris var \|\|\| \|\|\| P. vulgaris var \|\|\|(...TRUNCATED)

End of preview. Expand in Dataset Viewer.

Dataset Card for "beamit-annotated_full_texts_dataset"

More Information needed

Downloads last month: 1

Edit dataset card

Size of downloaded dataset files:

Size of the auto-converted Parquet files:

Number of rows: